BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 23290781)

  • 1. Sphingosine kinase 1 in cancer.
    Heffernan-Stroud LA; Obeid LM
    Adv Cancer Res; 2013; 117():201-35. PubMed ID: 23290781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase 1 as an anticancer therapeutic target.
    Gao Y; Gao F; Chen K; Tian ML; Zhao DL
    Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.
    Gault CR; Obeid LM
    Crit Rev Biochem Mol Biol; 2011 Aug; 46(4):342-51. PubMed ID: 21787121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine kinase and sphingosine-1-phosphate regulate epithelial cell architecture by the modulation of de novo sphingolipid synthesis.
    Santacreu BJ; Pescio LG; Romero DJ; Corradi GR; Sterin-Speziale N; Favale NO
    PLoS One; 2019; 14(3):e0213917. PubMed ID: 30897151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of targeting SK1 in human cancers.
    Alshaker H; Sauer L; Monteil D; Ottaviani S; Srivats S; Böhler T; Pchejetski D
    Adv Cancer Res; 2013; 117():143-200. PubMed ID: 23290780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sphingosine kinase 1 and tumor].
    Zhang CX; He HW; Shao RG
    Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles, regulation and inhibitors of sphingosine kinase 2.
    Neubauer HA; Pitson SM
    FEBS J; 2013 Nov; 280(21):5317-36. PubMed ID: 23638983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives on the role of sphingosine 1-phosphate in cancer.
    Pyne S; Pyne NJ
    Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine 1-phosphate and cancer.
    Pyne NJ; El Buri A; Adams DR; Pyne S
    Adv Biol Regul; 2018 May; 68():97-106. PubMed ID: 28942351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
    Huwiler A; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.
    Watson DG; Tonelli F; Alossaimi M; Williamson L; Chan E; Gorshkova I; Berdyshev E; Bittman R; Pyne NJ; Pyne S
    Cell Signal; 2013 Apr; 25(4):1011-7. PubMed ID: 23314175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel sphingosine kinase 1 inhibitors.
    Xiang Y; Asmussen G; Booker M; Hirth B; Kane JL; Liao J; Noson KD; Yee C
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6119-21. PubMed ID: 19800228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of regulation of sphingosine kinase 1.
    Pulkoski-Gross MJ; Obeid LM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Nov; 1863(11):1413-1422. PubMed ID: 30591148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
    Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
    Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha.
    Pettus BJ; Bielawski J; Porcelli AM; Reames DL; Johnson KR; Morrow J; Chalfant CE; Obeid LM; Hannun YA
    FASEB J; 2003 Aug; 17(11):1411-21. PubMed ID: 12890694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
    Yan G; Chen S; You B; Sun J
    Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
    Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases.
    Adams DR; Pyne S; Pyne NJ
    Cell Signal; 2020 Dec; 76():109806. PubMed ID: 33035646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.